Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Running at 40%

Re: "The February signings should also be in the Q report."

Why?

That could happen only if their last Q report was manipulated to increase earnings in future Q. I don't think that's allowed.

Share
New Message
Please login to post a reply